Regulatory Alerts2017-01-27
Added · Updated
OTC Derivative Transactions – Phase 2 Reporting
The regulator issued this circular on January 27, 2017, to provide guidance on the Phase 2 reporting requirements for OTC derivative transactions. The document serves as an enclosure containing a letter regarding training and testing protocols for market participants. It references related regulatory instruments concerning the migration to the new reporting regime and interim reporting requirements established in previous years.
Topics
Share